Literature DB >> 33343251

Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder.

Brian J Miller1, David R Goldsmith1.   

Abstract

The investigation of immune system abnormalities in schizophrenia, although ongoing for decades, has become a popular area of research. The authors present a selected review of studies informing on schizophrenia as a potential inflammatory disorder, emphasizing replicated findings. The authors summarize evidence for inflammation over the illness course, discuss relationships between inflammation and psychopathology, present studies of imaging of neuroinflammation, consider inflammation as a marker of treatment response and treatment target, and review potential mechanisms for the effects of inflammation on the brain in schizophrenia. Although there is not clear and convincing evidence to support the assertion that schizophrenia is an inflammatory disorder, this area of study shows promise toward a greater understanding of the etiopathophysiology of this heterogeneous disorder.
Copyright © by the American Psychiatric Association.

Entities:  

Keywords:  Cytokines; Immune system; Inflammation; Neuroimmunology; Schizophrenia

Year:  2020        PMID: 33343251      PMCID: PMC7725151          DOI: 10.1176/appi.focus.20200015

Source DB:  PubMed          Journal:  Focus (Am Psychiatr Publ)        ISSN: 1541-4094


  125 in total

1.  Metagenomic Sequencing Indicates That the Oropharyngeal Phageome of Individuals With Schizophrenia Differs From That of Controls.

Authors:  Robert H Yolken; Emily G Severance; Sarven Sabunciyan; Kristin L Gressitt; Ou Chen; Cassie Stallings; Andrea Origoni; Emily Katsafanas; Lucy A B Schweinfurth; Christina L G Savage; Maria Banis; Sunil Khushalani; Faith B Dickerson
Journal:  Schizophr Bull       Date:  2015-02-09       Impact factor: 9.306

Review 2.  A systematic, quantitative review of blood autoantibodies in schizophrenia.

Authors:  Amaka Ezeoke; Andrew Mellor; Peter Buckley; Brian Miller
Journal:  Schizophr Res       Date:  2013-08-14       Impact factor: 4.939

3.  Interleukin 1 beta gene and risk of schizophrenia: detailed case-control and family-based studies and an updated meta-analysis.

Authors:  Masako Shibuya; Yuichiro Watanabe; Ayako Nunokawa; Jun Egawa; Naoshi Kaneko; Hirofumi Igeta; Toshiyuki Someya
Journal:  Hum Psychopharmacol       Date:  2014-01       Impact factor: 1.672

4.  Associations between Chlamydophila infections, schizophrenia and risk of HLA-A10.

Authors:  B Fellerhoff; B Laumbacher; N Mueller; S Gu; R Wank
Journal:  Mol Psychiatry       Date:  2006-11-14       Impact factor: 15.992

Review 5.  Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis.

Authors:  Rachel Upthegrove; Nuria Manzanares-Teson; Nicholas M Barnes
Journal:  Schizophr Res       Date:  2014-04-04       Impact factor: 4.939

6.  Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume.

Authors:  Paola Dazzan; Carmine M Pariante; Valeria Mondelli; Annamaria Cattaneo; Martino Belvederi Murri; Marta Di Forti; Rowena Handley; Nilay Hepgul; Ana Miorelli; Serena Navari; Andrew S Papadopoulos; Katherine J Aitchison; Craig Morgan; Robin M Murray
Journal:  J Clin Psychiatry       Date:  2011-05-18       Impact factor: 4.384

7.  Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study.

Authors:  Bram P Prins; Ali Abbasi; Anson Wong; Ahmad Vaez; Ilja Nolte; Nora Franceschini; Philip E Stuart; Javier Guterriez Achury; Vanisha Mistry; Jonathan P Bradfield; Ana M Valdes; Jose Bras; Aleksey Shatunov; Chen Lu; Buhm Han; Soumya Raychaudhuri; Steve Bevan; Maureen D Mayes; Lam C Tsoi; Evangelos Evangelou; Rajan P Nair; Struan F A Grant; Constantin Polychronakos; Timothy R D Radstake; David A van Heel; Melanie L Dunstan; Nicholas W Wood; Ammar Al-Chalabi; Abbas Dehghan; Hakon Hakonarson; Hugh S Markus; James T Elder; Jo Knight; Dan E Arking; Timothy D Spector; Bobby P C Koeleman; Cornelia M van Duijn; Javier Martin; Andrew P Morris; Rinse K Weersma; Cisca Wijmenga; Patricia B Munroe; John R B Perry; Jennie G Pouget; Yalda Jamshidi; Harold Snieder; Behrooz Z Alizadeh
Journal:  PLoS Med       Date:  2016-06-21       Impact factor: 11.069

8.  Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder.

Authors:  Thomas A Lanz; Veronica Reinhart; Mark J Sheehan; Stacey J Sukoff Rizzo; Susan E Bove; Larry C James; Dmitri Volfson; David A Lewis; Robin J Kleiman
Journal:  Transl Psychiatry       Date:  2019-05-23       Impact factor: 6.222

9.  A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis.

Authors:  Toby Pillinger; Emanuele F Osimo; Stefan Brugger; Valeria Mondelli; Robert A McCutcheon; Oliver D Howes
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

10.  CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature.

Authors:  Antoine Louveau; Jasmin Herz; Maria Nordheim Alme; Andrea Francesca Salvador; Michael Q Dong; Kenneth E Viar; S Grace Herod; James Knopp; Joshua C Setliff; Alexander L Lupi; Sandro Da Mesquita; Elizabeth L Frost; Alban Gaultier; Tajie H Harris; Rui Cao; Song Hu; John R Lukens; Igor Smirnov; Christopher C Overall; Guillermo Oliver; Jonathan Kipnis
Journal:  Nat Neurosci       Date:  2018-09-17       Impact factor: 24.884

View more
  4 in total

Review 1.  Brick by Brick: Building a Transdiagnostic Understanding of Inflammation in Psychiatry.

Authors:  David S Thylur; David R Goldsmith
Journal:  Harv Rev Psychiatry       Date:  2022 Jan-Feb 01       Impact factor: 3.732

2.  Bipolar I Disorder Exacerbation Following COVID-19 Vaccination.

Authors:  Jeffrey Guina; Sara Barlow; Duren Gutierrez
Journal:  Innov Clin Neurosci       Date:  2022 Jul-Sep

3.  Psychopathology and Stem Cell Mobilization in Ultra-High Risk of Psychosis and First-Episode Psychosis Patients.

Authors:  Katarzyna Waszczuk; Jolanta Kucharska-Mazur; Ernest Tyburski; Katarzyna Rek-Owodziń; Piotr Plichta; Krzysztof Rudkowski; Piotr Podwalski; Tomasz Grąźlewski; Monika Mak; Błażej Misiak; Anna Michalczyk; Maciej Tarnowski; Katarzyna Sielatycka; Angelika Szczęśniak; Karolina Łuczkowska; Barbara Dołęgowska; Marta Budkowska; Mariusz Z Ratajczak; Jerzy Samochowiec
Journal:  Int J Environ Res Public Health       Date:  2022-05-15       Impact factor: 4.614

Review 4.  Cytokine Imbalance as a Biomarker of Treatment-Resistant Schizophrenia.

Authors:  Natalia A Shnayder; Aiperi K Khasanova; Anna I Strelnik; Mustafa Al-Zamil; Andrey P Otmakhov; Nikolay G Neznanov; German A Shipulin; Marina M Petrova; Natalia P Garganeeva; Regina F Nasyrova
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.